Bexion Pharmaceuticals

bexion
Ann Thompson / WVXU

BXQ-350 to the common eye looks like some sort of alphanumeric mystery, but in reality, it could become a life-saving tool in the fight against cancer.

bexion
Ann Thompson / WVXU

A new cancer drug previously reported on by WVXU has been green-lighted for a Phase 1 study on children. BXQ-350 is manufactured by Bexion Pharmaceuticals in Covington and was developed at Cincinnati Children's Hospital Medical Center, where it will be tested on children with solid tumors, brain tumors and diffuse intrinsic pontine gliomas (DIPG), a type of brain tumor. 

Ann Thompson / WVXU

A promising new cancer drug developed at Cincinnati Children's Hospital Medical Center and manufactured by Bexion Pharmaceuticals in Covington will soon be tested on children. BXQ-350 is already showing signs it's working on adults who have brain and gastrointestinal tumors.